A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma
Trial details
- Registry ID
- NCT03377179
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as HCQ
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced CholangiocarcinomaNCT03377179 | RedHill Biopharma Limited | Phase 2 | Completed | 2022-06-21Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |